Skip to main content
Cancer Explained
Beginner 6 min read Verified

Chemotherapy and Second Cancers

Why some cancer-fighting drugs can rarely cause a later cancer, which drugs are involved, and how care teams manage the risk — based on the National Cancer Institute.

NCI source

Last reviewed: 2026-07-05

The short answer

Some chemotherapy drugs that damage DNA can, rarely, cause a second cancer such as leukemia years later. The benefit of treating the original cancer usually far outweighs this small risk, and follow-up care watches for it.

  • Certain chemotherapy drugs is classified as a known human carcinogen (IARC Group 1).

  • People are mainly exposed by receiving certain DNA-damaging chemotherapy drugs.

  • It is most strongly linked to treatment-related leukemia.

  • A carcinogen classification describes hazard — whether something can cause cancer — not your personal risk at a given exposure.

Choose how you want to understand this

The full explanation.

The simple version

Certain chemotherapy drugs work by damaging the DNA of fast-growing cancer cells. That same action can, in rare cases, damage healthy cells enough to cause a new cancer years later. Doctors weigh this small risk against the much larger benefit of treating the cancer at hand.

What certain chemotherapy drugs is

Some drug classes — alkylating agents (like cyclophosphamide) and topoisomerase II inhibitors (like etoposide) — are linked to later treatment-related leukemia. These are recognized carcinogens, but they are used because treating a life-threatening cancer is the priority.

How people are exposed

Common ways people come into contact with it:

  • Receiving certain chemotherapy drugs, especially alkylating agents
  • Higher cumulative doses and combined treatments raise risk
  • Radiation combined with some chemo can add to risk

The cancer connection

The clearest link is to treatment-related acute leukemia, typically appearing a few years after treatment. Some regimens are also linked to other later cancers.

The International Agency for Research on Cancer (IARC), the cancer arm of the World Health Organization, places certain chemotherapy drugs in Group 1, carcinogenic to humans — the strongest evidence category, meaning there is enough evidence that it can cause cancer in people. In the United States, the National Toxicology Program's Report on Carcinogens lists it as known to be a human carcinogen.

Hazard is not the same as risk

It helps to separate two ideas that are easy to mix up: hazard and risk. When an agency lists certain chemotherapy drugs as a carcinogen, it is making a statement about hazard — whether the substance is capable of causing cancer under some conditions. It is not, by itself, a statement about your personal risk, which depends on how much you are exposed to, for how long, and other factors. Two substances in the same group can carry very different real-world risks. The label answers "can it cause cancer?" — not "how likely is it to cause cancer for me?"

How to lower your exposure

  • Care teams choose the lowest effective doses and regimens
  • Long-term survivorship follow-up watches for late effects
  • Report new, unexplained symptoms to your team

If you are looking at your overall cancer risk, small, steady steps add up. See our overview of cancer prevention and what raises cancer risk to put any single exposure in context.

The bottom line

Certain chemotherapy drugs is a known human carcinogen (IARC Group 1). The most important thing you can do is understand where exposure comes from and take reasonable steps to reduce it, without losing sleep over a single label. Focus your energy on the biggest, most controllable risks in your own life.

Words to know

Tap any term to see what it means.

Browse the full glossary →

Common questions

Does certain chemotherapy drugs cause cancer?

Yes. Certain chemotherapy drugs is classified as a known human carcinogen, which means there is strong evidence it can cause cancer in people. How much any one person's risk rises depends on how much they are exposed to and for how long.

How are people exposed to certain chemotherapy drugs?

Most exposure happens by receiving certain DNA-damaging chemotherapy drugs. These are prescribed, life-saving treatments; the small second-cancer risk is weighed against a large benefit.

Which cancers are linked to certain chemotherapy drugs?

It is most strongly linked to treatment-related leukemia.

How can I reduce my exposure to certain chemotherapy drugs?

The main steps are careful regimen choice and long-term survivorship follow-up.

Does a carcinogen label mean I will get cancer?

No. A classification is about hazard — whether certain chemotherapy drugs can cause cancer under some conditions — not a prediction that any one exposed person will develop cancer. Your actual risk depends on the amount and length of exposure and other factors.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Quick quiz

Test your knowledge

0 of 4 answered

  1. Q1.How do health agencies classify certain chemotherapy drugs?
  2. Q2.According to this article, how are people most often exposed to certain chemotherapy drugs?
  3. Q3.Certain chemotherapy drugs is most strongly linked to which cancer?
  4. Q4.What does it mean that certain chemotherapy drugs is classified as a carcinogen?

This quiz checks understanding of educational content only. It is not medical advice. Open this quiz on its own page.

Related learning map

How this explanation connects to 13 other things you can explore — related topics, terms, questions, practice, and its NCI source.

Chemotherapy and Second Cancers